Representing Animals Foundation
23.4.2024 18:04:14 CEST | ACCESS Newswire | Press release
WINCHESTER, UK / ACCESSWIRE / April 23, 2024 / The longest, most comprehensive peer-reviewed study so far has demonstrated that dogs fed nutritionally-sound vegan diets maintain health outcomes as well as dogs fed meat. The study, published in leading scientific journal PLOS ONE, comprehensively assessed the health of 15 dogs by analysing blood cells and biochemistry, blood nutrient levels, urine, veterinary clinical parameters, and monthly pet owner questionnaires. The dogs were fed solely vegan diets based on pea protein for an entire year - just under one tenth of an average dog lifespan, or around seven human years.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.Overweight or obese dogs lost weight, whilst the remainder maintained normal weight. No clinically significant changes occurred within blood and urine. Blood levels of amino acids and vitamins were all generally maintained.
In a few cases, previous deficiencies following a meat-based diet either improved or disappeared, including L-taurine and L-carnitine (important for cardiac health), vitamin D (indispensable for immunity and bone health), and folate (required to produce red blood cells).
The study was particularly interesting, given recent suggestions that peas might contribute to heart disease in dogs in the US. Although no credible evidence has been found, such concerns have persisted in some quarters. In the current study, dogs were fed pea-based vegan pet food, for one year. Blood markers of cardiac health were assessed, with no signs of heart disease found. Indeed, in some cases indicators of cardiac health improved.
Stated lead researcher, veterinarian Dr. Annika Linde from the Western University of Health Sciences near Los Angeles says, "Evolutionary adaptations have resulted in a digestive system that enables dogs to maintain health on nutritionally complete omnivorous diets, including those free of animal ingredients. Our study offers new evidence on outcomes in clinically healthy dogs who thrive without consumption of animal-derived ingredients. Notably, foods produced independent of factory farming are also more sustainable and ethical."
Study co-author Dr. Melgarejo highlighted the potential environmental benefits of such diets, "If dogs and cats in the U.S. were their own nation, they would rank fifth in global meat consumption, surpassed only by Russia, Brazil, USA, and China, according to the UCLA Institute of the Environment and Sustainability."
Veterinary Professor Andrew Knight has published several of the key studies in this field, including very large-scale studies showing that both dogs and cats normally achieve equivalent or superior health outcomes, when fed nutritionally-sound vegan diets. He also analysed the environmental benefits of vegan pet diets in a major recent study. He stated that "If all the world's dogs went vegan, it would save more greenhouse gases than those emitted by the UK, land larger than Mexico, and 450 million additional people could be fed with food energy savings - more than the entire EU population. With 13 studies now demonstrating good health outcomes achieved by nutritionally-sound vegan pet diets, and several others demonstrating major environmental benefits, a compelling case now exists for environmentally-friendly vegan pet diets."
Contact Information:
Andrew Knight
Veterinary Professor of Animal Welfare
andrew.knight@winchester.ac.uk
SOURCE: Representing Animals Foundation
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Fermi Announces New Agreements with Investment-Grade Hyperscaler and Third Quarter 2026 Financial Results12.11.2026 13:00:00 CET | Press release
DALLAS, TX / ACCESS Newswire / November 12, 2026 / Fermi Inc. (NASDAQ:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), today announced its third quarter 2026 financial results and multiple new agreements with an investment-grade hyperscaler to advance 600 megawatts ("MW") of power capacity at Project Matador. A conference call is scheduled for 9 a.m. Eastern Time / 2 p.m. British Time today, November 12, 2026. Accompanying slides and prepared remarks can be found at https://investor.fermiamerica.com. Participation details are included in this release. "Hyperscalers want sites that are ready with permitted power, and Fermi's Project Matador is one of few that can meet that demand today," said Lee McIntire, Fermi Chief Executive Officer. "Our headstart in speed to power is a key reason an investment-grade hyperscaler has signed up for 600 megawatts and committed more than $200 million up front to accelerate construction at Project Matador with an additional $90 mi
Nexteer Announces First Share Repurchase Programme of Up to US$60 Million12.11.2026 01:40:00 CET | Press release
HONG KONG, HK / ACCESS Newswire / November 11, 2026 / Nexteer Automotive today announced that its Board of Directors has approved, the Company's first share repurchase programme of up to US$60 million, equivalent to approximately HK$471 million. The programme reflects the Board's confidence in Nexteer's business and long-term prospects. The Group's strong liquidity position supports returning capital to shareholders while continuing to invest in the business and its future development. Disciplined Capital Allocation The programme complements Nexteer's dividend distributions and represents a further step in returning capital to shareholders. It follows the dividend paid out in July 2026 of approximately US$46 million, representing 45% of the Company's net income attributable to shareholders for the year ending December 31, 2025 -and the highest dividend payout ratio in the Company's history. Nexteer remains committed to disciplined capital allocation, balancing investment in the busines
GoodData.AI Launches the Agentic Serving Plane, a New Category of Enterprise Data Infrastructure for AI Agents10.11.2026 15:30:00 CET | Press release
SAN FRANCISCO, CA / ACCESS Newswire / November 10, 2026 / GoodData.AI, the open agentic analytics platform, today launched the Agentic Serving Plane, a governed execution layer designed for the high-concurrency, context-rich data workloads created by AI agents. The Agentic Serving Plane sits between enterprise data platforms and the applications, analytics experiences and agents that consume them. It provides workload serving, business semantics, contextual grounding, access control, and AI execution services through a common governed layer. The current enterprise data infrastructure was designed primarily for humans: occasional queries, predictable workloads, and access by known users. AI agents operate differently. A single business task can generate tens or hundreds of short-lived data operations as an agent investigates, reasons, and decides what to ask next. When many agents operate simultaneously, intermittent human querying becomes continuous, high-concurrency agentic demand. Ag
Envision Pharma Group appoints Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian10.11.2026 15:00:00 CET | Press release
FAIRFIELD, CT / ACCESS Newswire / November 10, 2026 / Envision Pharma Group (Envision), a global, technology-enabled solutions partner to the life sciences industry, has appointed Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian. Siino will lead a team providing best-in-class launch and revenue management services to the biopharma community. Pharma and biotech companies across the industry seek suppliers who can support them from their earliest stages, often before they have built in-house commercial, market access, and revenue management capabilities. Two Labs provides commercialization services and consulting support as these companies prepare for and execute successful launches; Riparian offers consulting, managed services, and technology to manage and protect revenue as their therapies reach patients. Together, Envision's Two Labs and Riparian businesses offer a single, connected solution spanning launch and beyond. Under Siino's leadership, clients wi
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations10.11.2026 14:00:00 CET | Press release
LINCOLN, NE / ACCESS Newswire / November 10, 2026 / Securitas Healthcare, a leading provider of real-time visibility and protection solutions for the healthcare industry, today announced the next generation of its MobileView® Real-Time Location System (RTLS) platform. The expanded platform introduces MobileView Cloud, new solution capabilities, enhanced user experiences, and flexible deployment, technology, and integration options that help healthcare organizations transform real-time visibility into operational intelligence. As health systems navigate workforce shortages, capacity constraints, and growing demands for efficiency and better patient experiences, timely access to operational and clinical information has become essential to managing increasingly complex care environments. Today's RTLS platforms provide the visibility and intelligence needed to improve patient throughput, enhance safety, optimize resource utilization, and support the connected operations required to enable
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
